HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Paracetamol Included In EU List Of Critical Medicines

Executive Summary

Paracetamol makes it onto the European Commission's first ever EU-level list of critical medicines whose continuity of supply is a priority and for which “shortages should be avoided.”

You may also be interested in...



EU Critical Medicines List To Be Ready ‘Within Days’

Members of the European Parliament were told that once the list was out, work would begin on identifying the products most vulnerable to supply chain problems.

EU Floats Raft Of Plans To Tackle ‘Critical’ Drug Shortages

The European Commission says the collective actions it is proposing should allow it to work more closely with the pharmaceutical industry and help EU member states improve the security of medicines supply.

AESGP Welcomes EU Pharma Revision But Warns Of ‘Unintended Negative Consequences’

European self-care industry association AESGP says it supports the revision of the EU pharmaceutical legislation “in principle,” but has concerns that some of the proposals “may have unintended negative consequences.”

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel